Carcinoma in situ of the vulva is a non-invasive form of cancer characterized by abnormal cell growth confined to the vulvar epithelium. It is clinically significant due to its potential progression to invasive cancer if left untreated. The ICD-10 Code D07.1 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track and manage this condition.
ICD-10 Code D07.1 represents Carcinoma in situ of the vulva, indicating the presence of localized, non-invasive cancerous cells. This code is used in clinical documentation and billing when diagnosing patients with this condition, which may arise from factors such as HPV infection or chronic irritation. Accurate coding is essential for treatment planning and reimbursement.
Carcinoma in situ of the vulva is primarily caused by factors such as human papillomavirus (HPV) infection, chronic inflammation, or irritation. It is crucial to address this condition promptly to prevent progression to invasive cancer. Regular screening and early intervention are vital for effective management.
ICD-10 Code D07.1 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans. It plays a critical role in both acute and chronic care settings, ensuring comprehensive documentation and facilitating appropriate billing for services rendered.
In SOAP notes, ICD-10 Code D07.1 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Carcinoma in situ of the vulva. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Prompt treatment of Carcinoma in situ of the vulva is essential to prevent progression to invasive cancer. Treatment options may include surgical excision or topical therapies.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code D07.1 is crucial for accurate billing in hospital, ER, or outpatient settings, ensuring proper reimbursement for services related to Carcinoma in situ of the vulva.
| CPT Code | Description |
|---|---|
| 12001 | Simple repair of superficial wounds, face, ears, eyelids, scalp, neck. |
| 11420 | Excision, benign lesion including margins, face, ears, eyelids, scalp, neck. |
| 58661 | Laparoscopy, surgical; with fulguration of endometriosis. |
| 88305 | Level IV surgical pathology, gross and microscopic examination. |
Common Questions About Using ICD-10 Code D07.1 for Carcinoma in situ of vulva
What are the risk factors for Carcinoma in situ of the vulva?
Risk factors include HPV infection, smoking, immunosuppression, and chronic vulvar irritation. Women with a history of vulvar lesions or those who are immunocompromised are at higher risk.
How is Carcinoma in situ of the vulva diagnosed?
Diagnosis typically involves a physical examination, biopsy of the vulvar lesions, and histopathological analysis to confirm the presence of carcinoma in situ.
What treatment options are available for Carcinoma in situ of the vulva?
Treatment options include surgical excision of the lesions, topical chemotherapy, and close monitoring. The choice of treatment depends on the extent and characteristics of the lesions.
Is Carcinoma in situ of the vulva contagious?
Carcinoma in situ of the vulva is not contagious. However, the underlying HPV infection can be transmitted through sexual contact, highlighting the importance of vaccination and safe practices.
Clinical Notes
SOAP notes
DAP notes
AI medical notes